Intravitreal Anti–Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic

This cohort study uses data from the French National Health Data System to assess the decline in the use of intravitreal anti–vascular endothelial growth factors before, during, and after pandemic-associated lockdown periods.

Detalles Bibliográficos
Autores principales: Billioti de Gage, Sophie, Drouin, Jérôme, Desplas, David, Cuenot, François, Dray-Spira, Rosemary, Weill, Alain, Zureik, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747036/
https://www.ncbi.nlm.nih.gov/pubmed/33331873
http://dx.doi.org/10.1001/jamaophthalmol.2020.5594
_version_ 1783624912722722816
author Billioti de Gage, Sophie
Drouin, Jérôme
Desplas, David
Cuenot, François
Dray-Spira, Rosemary
Weill, Alain
Zureik, Mahmoud
author_facet Billioti de Gage, Sophie
Drouin, Jérôme
Desplas, David
Cuenot, François
Dray-Spira, Rosemary
Weill, Alain
Zureik, Mahmoud
author_sort Billioti de Gage, Sophie
collection PubMed
description This cohort study uses data from the French National Health Data System to assess the decline in the use of intravitreal anti–vascular endothelial growth factors before, during, and after pandemic-associated lockdown periods.
format Online
Article
Text
id pubmed-7747036
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-77470362020-12-21 Intravitreal Anti–Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic Billioti de Gage, Sophie Drouin, Jérôme Desplas, David Cuenot, François Dray-Spira, Rosemary Weill, Alain Zureik, Mahmoud JAMA Ophthalmol Research Letter This cohort study uses data from the French National Health Data System to assess the decline in the use of intravitreal anti–vascular endothelial growth factors before, during, and after pandemic-associated lockdown periods. American Medical Association 2020-12-17 2021-02 /pmc/articles/PMC7747036/ /pubmed/33331873 http://dx.doi.org/10.1001/jamaophthalmol.2020.5594 Text en Copyright 2020 Billioti de Gage S et al. JAMA Ophthalmology. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Billioti de Gage, Sophie
Drouin, Jérôme
Desplas, David
Cuenot, François
Dray-Spira, Rosemary
Weill, Alain
Zureik, Mahmoud
Intravitreal Anti–Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic
title Intravitreal Anti–Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic
title_full Intravitreal Anti–Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic
title_fullStr Intravitreal Anti–Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic
title_full_unstemmed Intravitreal Anti–Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic
title_short Intravitreal Anti–Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic
title_sort intravitreal anti–vascular endothelial growth factor use in france during the coronavirus disease 2019 pandemic
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747036/
https://www.ncbi.nlm.nih.gov/pubmed/33331873
http://dx.doi.org/10.1001/jamaophthalmol.2020.5594
work_keys_str_mv AT billiotidegagesophie intravitrealantivascularendothelialgrowthfactoruseinfranceduringthecoronavirusdisease2019pandemic
AT drouinjerome intravitrealantivascularendothelialgrowthfactoruseinfranceduringthecoronavirusdisease2019pandemic
AT desplasdavid intravitrealantivascularendothelialgrowthfactoruseinfranceduringthecoronavirusdisease2019pandemic
AT cuenotfrancois intravitrealantivascularendothelialgrowthfactoruseinfranceduringthecoronavirusdisease2019pandemic
AT drayspirarosemary intravitrealantivascularendothelialgrowthfactoruseinfranceduringthecoronavirusdisease2019pandemic
AT weillalain intravitrealantivascularendothelialgrowthfactoruseinfranceduringthecoronavirusdisease2019pandemic
AT zureikmahmoud intravitrealantivascularendothelialgrowthfactoruseinfranceduringthecoronavirusdisease2019pandemic

Ejemplares similares